🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of this trial are: * To evaluate the effect of a hi...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2018-08-16
Trial ID
NCT03647202
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of milademetan...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2018-12-17
Trial ID
NCT03634228
Treatments Being Tested
This is an open-label, single-arm, Phase 1b/2 study designed to evaluate th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05-19
Trial ID
NCT06090318
Treatments Being Tested
This will be a Phase 1, open-label study of milademetan to assess its safet...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2013-07-11
Trial ID
NCT01877382
Treatments Being Tested
This is a Phase 1, multicenter, open-label study to evaluate safety, tolera...
Status
Completed
Location
Japanese Red Cross Narita Hospital
Start Date
2018-08-23
Trial ID
NCT03671564
Treatments Being Tested
Phase 2, multicenter, single-arm, open-label basket study designed to evalu...
Status
Terminated
Location
Stanford University Medical Center
Start Date
2021-11-01
Trial ID
NCT05012397
Treatments Being Tested
Randomized, multicenter, open-label, Phase 3 registration study designed to...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2021-07-14
Trial ID
NCT04979442
Treatments Being Tested
This will be a Phase 1, single-center, 2-part study in healthy subjects. Pa...
Status
Terminated
Location
Nucleus Network Melbourne
Start Date
2023-04-17
Trial ID
NCT05758818
Treatments Being Tested
Participants with AML that have gone into remission and come back (relapsed...
Status
Terminated
Location
Ronald Reagan Medical Center, UCLA
Start Date
2018-12-12
Trial ID
NCT03552029
Treatments Being Tested
This will be an open-label, randomized, 3-treatment, 2-period, 2-sequence s...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2018-07-13
Trial ID
NCT03614455
Treatments Being Tested